DBV Technologies | DBVT - EPS Earnings Per Share

Stock Price
19.65
Daily Change
-0.19 -0.96%
Monthly
-4.66%
Yearly
77.03%
Q2 Forecast
19.19

DBV Technologies reported $-0.24 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.





Eps Change Date
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Amarin USD 0.14 0.06 Dec/2025
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
DBV Technologies USD -0.24 1.31 Sep/2025
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Galectin Therapeutics USD -0.2 0.01 Jun/2024
Halozyme Therapeutics USD 1.6 1.84 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
Insmed USD -0.76 0.78 Mar/2026
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
PTC Therapeutics USD -0.03 1.64 Mar/2026
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
United Therapeutics USD 5.82 1.88 Mar/2026